Search clinical trials for: MHS552

Total 16 results

Novartis Pharmaceuticals

Withdrawn

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus
Novartis Pharmaceuticals

Terminated

Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

Germany
Hua Medicine Limited

Completed

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

Type 2 Diabetes Mellitus

China
Hua Medicine Limited

Completed

Human Mass Balance Study of HMS5552 in Healthy Subjects

Healthy Subject

United States
Hua Medicine Limited

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus
Hua Medicine Limited
Tigermed Consulting Co., Ltd

Completed

A Multi-center 12-week Study of HMS5552 in T2DM

Diabetes Mellitus, Type 2

China
Hua Medicine Limited

Completed

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers

Type 2 Diabetes Mellitus

China
Majianhua

Unknown

The Progress of Diabetes Mellitus After HMS5552 Treatment in Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus

China
Hua Medicine Limited

Completed

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers

Type II Diabetes Mellitus

China
Hua Medicine Limited

Completed

Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients

Type 2 Diabetes

China
Hua Medicine Limited
Tigermed Consulting Co., Ltd

Completed

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Diabetes Mellitus, Type 2

China
Hua Medicine Limited

Completed

DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin

Drug Interaction

China
Hua Medicine Limited
Covance

Completed

Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects

Diabetes Mellitus, Type 2

China
Hua Medicine Limited

Completed

Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM

Type 2 Diabetes Mellitus

United States
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Empagliflozin

Patients

United States
Hua Medicine Limited

Completed

Drug Interaction Study Between Dorzagliatin and Sitagliptin

Patients

United States

3

Subscribe